U.S. prisons are experimenting with a high-priced monthly injection that could help addicted inmates stay off opioids after they are released, but skeptics question its effectiveness and say the manufacturer has aggressively marketed an unproven drug to corrections officials, reports the Associated Press. A single shot of Vivitrol, given in the buttocks, lasts for four weeks and eliminates the need for . . .
Want to read more? Please subscribe to The Crime Report!